About the Company
Shriram Life Insurance Company Limited is an unlisted life insurance company established in 2005 and regulated by the Insurance Regulatory and Development Authority of India (IRDAI). It is part of the Shriram Group and operates in partnership with Sanlam, a leading South African financial-services and insurance group.
The company offers protection, savings, ULIP, retirement, child and microinsurance products, with a particular focus on serving India’s mass-market and emerging customer segments. (Shriram Life)
As of March 2026, Shriram Life had 729 offices, over 2,000 individual agents, 388 POSPs and premium income of approximately ₹4,967 Cr.
Key Highlights
- Established: 2005
- Business: Life Insurance
- Status: Unlisted
- IRDAI Registration: 128
- Shriram Group-backed
- Sanlam-backed
- FY26 Premium Income: ₹4,967 Cr
- FY26 New Business Premium: ₹2,425 Cr
- FY26 Renewal Premium: ₹2,542 Cr
- Funds Under Management: ₹15,216 Cr
- Sum Assured in Force: ₹3,35,176 Cr
- Branches/Offices: 729
- Solvency Ratio: 158%
- FY26 Individual New Business Growth: ~21%
Business Model
Shriram Life earns primarily through insurance premiums, invests policyholder funds according to IRDAI regulations and earns investment income while managing long-term insurance liabilities.
Protection Products
The company offers term and protection products designed to provide financial security to families. (Shriram Life)
Savings & Guaranteed Products
Traditional savings products combine life insurance protection with long-term savings and guaranteed/participating benefits.
ULIPs
Shriram Life offers market-linked insurance products such as Shriram Life Wealth Pro, Fortune Builder and Golden Jubilee Plan, providing life cover alongside investment options. (Shriram Life)
Retirement & Annuity
The company provides pension and annuity products designed to generate income during retirement. (Shriram Life)
Microinsurance
Microinsurance remains an important part of the company’s financial-inclusion strategy, targeting customers with relatively smaller insurance requirements.
Financial Snapshot
| Particulars | FY24 | FY25 | FY26 |
|---|---|---|---|
| Premium Income | ~₹3,507 Cr | ₹4,216 Cr | ₹4,967 Cr |
| New Business Premium | — | ₹2,277 Cr | ₹2,425 Cr |
| Renewal Premium | — | ₹1,939 Cr | ₹2,542 Cr |
| Funds Under Management | — | ₹13,207 Cr | ₹15,216 Cr |
| PAT | ~₹158 Cr | ₹66 Cr | -₹26 Cr |
| Solvency Ratio | 204% | 179% | 158% |
FY26 saw strong premium growth, with total premium income increasing from ₹4,216 Cr to ₹4,967 Cr. Individual new business also grew approximately 21%, ahead of both the private-insurer industry and LIC. However, shareholder-account PAT turned negative at ₹26 Cr, while operating expenses from the policyholders’ account increased significantly.
This is an important point: the company’s topline and business volumes are growing strongly, but profitability and solvency need to be monitored closely.
Shareholding Pattern
The ownership structure has changed significantly during 2026.
As of March 31, 2026:
| Shareholder | Holding |
|---|---|
| Shriram Capital Pvt. Ltd. | 46.98% |
| Sanlam Emerging Markets | 49.25% |
| Others | 3.76% |
During 2026, Sanlam acquired shares from Piramal Finance, TPG India Investments II and the Shriram Ownership Trust. Piramal Finance subsequently completed the sale of its entire 14.72% stake to Sanlam for ₹600 Cr.
In addition, Shriram Life issued 1.90 Cr new shares to Sanlam at ₹116/share in April 2026. After this preferential issue, Sanlam’s direct holding crossed 50%, while its effective shareholding was reported at approximately 65.68%, subject to the relevant regulatory approval. (cdn.shriramlife.com)
This makes Sanlam the dominant strategic shareholder in Shriram Life.
Valuation & Market Position
Shriram Life Insurance remains unlisted and its equity shares trade in the OTC/unlisted market.
Current market indications vary significantly. One source reported approximately ₹525/share as of September 8, 2026, while another reported around ₹260/share for the same date. This large difference demonstrates the limited price discovery and liquidity of unlisted shares. (BuyUnlistedShares)
Importantly, Sanlam’s recent preferential acquisition was completed at ₹116/share, which provides a useful institutional transaction reference point, although it should not be treated as the current fair value. (BuyUnlistedShares)
At ₹525, using the post-issue share count of approximately 20.86 Cr shares, the implied equity value would be around ₹10,950 Cr. At ₹260, it would be around ₹5,420 Cr.
Therefore, valuation is currently the biggest question for an investor entering through the unlisted market.
Investment Rationale
| Positives | Key Concerns |
|---|---|
| Strong Shriram Group brand & distribution | Company reported loss in FY26 |
| Sanlam as dominant strategic shareholder | Solvency declined to 158% |
| Premium growth of ~18% in FY26 | Operating expenses increased sharply |
| Individual new business grew ~21% | Unlisted-share liquidity is limited |
| ₹15,216 Cr funds under management | Valuation varies substantially across OTC sources |
| 729-office network | Life insurance requires significant capital |
| Large underserved customer opportunity | Insurance profitability can be volatile |
| Potential benefit from Sanlam’s global insurance expertise | Regulatory and actuarial risks |
Major Catalyst — Sanlam Control
The most important development for Shriram Life is the increased ownership and control of Sanlam.
Sanlam has been a strategic partner of Shriram Life for many years, but its ownership increased materially following the acquisition of shares from existing investors and the 2026 preferential issue.
This could potentially provide:
- Stronger capital support
- Global insurance expertise
- Better product capabilities
- Improved technology and risk-management systems
- Greater access to international insurance practices
- Potential strategic restructuring or future capital-market activity
However, there is currently no confirmed IPO timetable that should be assumed as part of the investment thesis.
Growth Opportunity
India’s life-insurance penetration remains below many developed markets, leaving significant room for long-term growth.
Shriram Life has an interesting positioning because it combines:
Shriram’s mass-market distribution + Sanlam’s insurance expertise + India’s growing insurance demand
The company’s FY26 performance shows strong momentum in individual new business, while its FUM increased to ₹15,216 Cr.
The expansion of POSPs from 84 to 388 during FY26 also indicates an effort to diversify distribution beyond traditional agency channels.
Risk Factors
- Profitability Risk: FY26 shareholder-account PAT was a ₹26 Cr loss.
- Solvency Risk: Solvency ratio declined from 179% to 158%, although it remains above the regulatory minimum of 150%.
- Expense Risk: Policyholder-account operating expenses increased substantially.
- Capital Requirement: Life insurance businesses require significant long-term capital.
- Regulatory Risk: Insurance companies are heavily regulated by IRDAI.
- Market Risk: Investment returns can affect profitability and shareholder value.
- Liquidity Risk: Equity shares are unlisted.
- Valuation Risk: Current OTC prices vary substantially between market sources.
- Execution Risk: Strong premium growth must ultimately translate into sustainable profitability.
- Integration/Control Changes: Sanlam’s increased control could lead to future strategic changes.
Share Details
| Particular | Details |
|---|---|
| Company | Shriram Life Insurance Company Limited |
| Status | Unlisted |
| Sector | Life Insurance |
| CIN | U66010TG2005PLC045616 |
| IRDAI Registration | 128 |
| ISIN | INE227H01016 |
| Face Value | ₹10 |
| FY26 Paid-up Capital | ₹181.84 Cr |
| FY26 Premium Income | ₹4,967 Cr |
| FY26 FUM | ₹15,216 Cr |
| Solvency Ratio | 158% |
| Indicative Unlisted Price | ~₹260–₹525* |
*OTC indications vary considerably and should not be treated as an exchange-traded price. (BuyUnlistedShares)
How to Invest
Shriram Life Insurance shares can be purchased through the unlisted-share market through intermediaries dealing in unlisted securities.
Investors should verify the latest executable price, ISIN, share availability, lot size, transfer mechanism and applicable taxation before placing an order.
Investment View
Shriram Life Insurance is an interesting unlisted insurance play, but the valuation needs to be considered very carefully.
The strongest part of the story is the combination of Shriram’s established distribution network, strong premium growth and Sanlam’s increasing strategic control.
FY26 showed impressive business growth, with premium income rising to ₹4,967 Cr and individual new business growing approximately 21%. However, the company reported a ₹26 Cr shareholder-account loss, while solvency declined to 158%.
The Sanlam transaction at ₹116/share is particularly relevant because it represents a recent institutional transaction price. However, the current OTC market indications of ₹260–₹525 imply a very wide premium over that transaction price. (cdn.shriramlife.com)
Overall View
Good business + strong strategic shareholder + strong premium growth — but valuation-sensitive.
For an investor buying at the lower end of the current unlisted range, the risk/reward looks considerably more attractive than buying at ₹500+, where expectations appear much higher.
Investment View: Positive for long-term investors, but only at a valuation that provides sufficient margin of safety.
Disclaimer
This information is provided for educational and informational purposes only and should not be considered investment advice, an offer to buy or sell securities, or a recommendation to invest. Unlisted-share prices are indicative and can vary significantly based on liquidity, availability and transaction size. Investors should conduct their own due diligence and consult a SEBI-registered investment adviser before making investment decisions.
For more such unlisited stocks visit https://unlistedcart.com/unlisted-shares/
